Brief: Bubs Australia Sees Impairment Of About A$20 Mln In HY Results
27/02/2023 05:51
Feb 27 (Reuters) - Bubs Australia Ltd BUB.AX :
* SEES TO INCUR AN IMPAIRMENT OF APPROXIMATELY A$20M IN HY
RESULTS
* IMPAIRMENT UNDER ASSESSMENT IS A NON-CASH IMPAIRMENT,
RELATED TO
DELORAINE DAIRY CASH GENERATING UNIT
Source text for Eikon: ID:nASX2dS1NX
Further company coverage: BUB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bubs Australia
See all newsBubs Australia hits near two-month low as quarterly revenue declines
Bubs Australia shares set for 15% weekly gain on FDA approval for infant formula products
Bubs Australia extends rally after infant formulas get US FDA approval
Bubs Australia gets permanent FDA nod for infant formula sales in US, shares jump (updated)
Bubs Australia secures permanent FDA nod for infant formula sales in US, shares jump